Total Compensation Measurement. Global TCM Participants. Turkey
|
|
|
- Cecily Curtis
- 10 years ago
- Views:
Transcription
1 Total Compensation Measurement 2008 Global TCM Participants Turkey
2 Turkey 2008 TCM Participants Summary Information The table below lists key summary information on the 67 TCM participants for Measure Sales (Fiscal year 2007in YTL) Average Median Number of White Collars Average 270 Median 89 Number of Blue Collars Average 771 Median 203 Number of Employees Average 800 Median 247 Hewitt Associates 1 Turkey 2008 Hewitt Global TCM Participants
3 Ownership Ownership US Multinational 31% 21 European Multinational 66% 44 Asian Multinational 3% 4 US Multinational 31% Ownership Asian Multinational 3% European Multinational 66% Hewitt Associates 2 Turkey 2008 Hewitt Global TCM Participants
4 Industry Industry Representation Aerospace 1 Automotive/Vehicle Manufacturing 16.4% 11 Building Materials 3.0% 2 Chemicals 1 Consumer Products (durable) 4.5% 3 Consumer Products (non durable) 1 Engineering/Construction 1 Food/Beverage/Tobacco 6.0% 4 Hi-Tech 1 Hospitality/Restaurants 1 Medical Devices/Products 3.0% 2 Multi-Industry 1 Other Manufacturing 7.5% 5 Other Service 3.0% 2 Pharmaceutical 26.9% 18 Retail (Includes Wholesale and Distribution) 11.9% 8 Textiles/Apparel Manufacturing 1 Transport, Logistics 6.0% 4 Industry Textiles/Apparel Manufacturing Pharmaceutical 26.9% Other Service 3.0% Retail (Includes Wholesale and Distribution) 11.9% Transport, Logistics 6.0% Multi-Industry Aerospace Other Manufacturing 7.5% Automotive/Vehicle Building Materials Manufacturing 3.0% 16.4% Chemicals Consumer Products (durable) 4.5% Consumer Products (non durable) Food/Beverage/Tobacco 6.0% Hi-Tech Hospitality/Restaurants Engineering/Construction Medical Devices/Products 3.0% Hewitt Associates 3 Turkey 2008 Hewitt Global TCM Participants
5 Turkey 2008 TCM Participants - Alphabetical Order 3M Abbott Adil Işık Agility Logistics Air France AkçanSA Armada Hotel Astra Zeneca Autoliv Bak Ambalaj Bareks Baylas (Citroen) Baytur (Subaru) Boehringer Ingelheim Bosch Siemens Boston Scientific Bristol-Myers Squibb Brown-Forman C&A Cargill CarrefourSA Ceva Logistics Coca-Cola DHL Worldwide Express Docomo intertouch Edwards Lifesciences Eli Lilly and Company Emerson Process Management F Hoffmann-La Roche Ferroli Genzyme General Motors GlaxoSmithKline Gravure International Hal Optik Hal Optik Imperial Tobacco İnci Akü Intendis John Deere Johnson & Johnson Kimberly-Clark Laverda Mahle Mopisan MAN Mercedes-Benz Merck & Co Merck Serono Nalco Nike Novartis Pharma Omsan Logistics Özmaya Peugeot Pfizer Polibak Sandoz Schering-Plough Set Group Shaya Sodexho Teb Arval TeknoSA Tema Magazacilik (LC Waikiki) UCB Valeo Wyeth YKM Hewitt Associates 4 Turkey 2008 Hewitt Global TCM Participants
6 Turkey 2008 TCM Participants - by Industry Aerospace Air France Automotive/Vehicle Manufacturing Autoliv Baylas (Citroen) Baytur (Subaru) General Motors John Deere Laverda Mahle Mopisan MAN Mercedes-Benz Peugeot Valeo Building Materials AkçanSA Set Group Chemicals Nalco Consumer Products (durable) Bosch Siemens Brown-Forman Ferroli Consumer Products (nondurable) Kimberly-Clark Engineering/Construction Emerson Process Management Food/Beverage/Tobacco Cargill Coca-Cola Imperial Tobacco Özmaya Hi-Tech Docomo intertouch Hewitt Associates 5 Turkey 2008 Hewitt Global TCM Participants
7 Hospitality/Restaurants Armada Hotel Medical Devices/Products Boston Scientific Edwards Lifesciences Multi-Industry 3M Other Manufacturing Bak Ambalaj Bareks Gravure International İnci Akü Polibak Other Service Sodexho Teb Arval Pharmaceutical Abbott Astra Zeneca Boehringer Ingelheim Bristol-Myers Squibb Eli Lilly and Company F Hoffmann-La Roche Genzyme GlaxoSmithKline Intendis Johnson & Johnson Merck & Co Merck Serono Novartis Pharma Pfizer Sandoz Schering-Plough UCB Wyeth Retail (Includes Wholesale & Distribution) Adil Işık C&A CarrefourSA Hal Optik Shaya TeknoSA Tema Magazacilik (LC Waikiki) YKM Transportation services Nike Hewitt Associates 6 Turkey 2008 Hewitt Global TCM Participants
8 Transport, Logistics Agility Logistics Ceva Logistics DHL Worldwide Express Omsan Logistics Hewitt Associates 7 Turkey 2008 Hewitt Global TCM Participants
Organizational Capital, R&D Assets, and Outsourcing
Organizational Capital, R&D Assets, and Outsourcing Wendy Li 2013 Federal Committee on Statistical Methodology Research Conference Bureau of Economic Analysis November 5, 2013 Motivation and Challenge
CHEM-E4140 Selectivity 12. Pharma Business
CHEM-E4140 Selectivity 12. Pharma Business Prof. Ari Koskinen Laboratory of Organic Chemistry C318 Pharma Business Total volume ca 1100 G$ (Shell 421G$; Walmart 486G$; Toyota 252 G$). Annually approx 25
December 17, 2014 HOW PHARMA MARKETERS FIND AND SELECT DIGITAL MARKETING AGENCIES
December 17, 2014 HOW PHARMA MARKETERS FIND AND SELECT DIGITAL MARKETING AGENCIES by Dennis van Rooij with Tim van Tongeren EXECUTIVE SUMMARY More than half of pharma marketers don t or can t leverage
Serialization Technology - Seidenader: Integral Solution Provider
Serialization Technology - Seidenader: Integral Solution Provider Sindusfarma August, 28th 2013 Dr. Stefan Loelkes Agenda 1 2 Your challenge Company overview 3 4 Integral solution provider Products 2 Your
Global Non-Small Cell Lung Cancer Therapeutics Market 2015-2019
Brochure More information from http://www.researchandmarkets.com/reports/3453273/ Global Non-Small Cell Lung Cancer Therapeutics Market 2015-2019 Description: About non-small cell lung cancer therapeutics
ehealthinsight Series: Online Patient Recruitment Strategies
A Datamonitor report ehealthinsight Series: Online Patient Recruitment Strategies Published: May-08 Product Code: Providing you with: Overview of benefits and drawbacks of online Analysis of online patient
Tuas Biomedical Park
Tuas Biomedical Park About Tuas Biomedical Park Tuas Biomedical Park symbolises JTC s commitment in developing a world-class manufacturing hub for the biomedical industry. The park is located in Tuas View,
Outcomes of Monitoring Committee Reviews. Medicines Australia Code of Conduct
Outcomes of Monitoring Committee Reviews Medicines Australia Code of Conduct 1 Medicines Australia ABN 23 126 990 001 Level 1, 16 Napier Close Deakin ACT 2600 Phone: 02 6122 8500 Fax: 02 6122 8555 Web:
Top ICT spenders in the US Pharmaceutical Industry - Estimated ICT budget breakdowns in 2013
Brochure More information from http://www.researchandmarkets.com/reports/2599260/ Top ICT spenders in the US Pharmaceutical Industry - Estimated ICT budget breakdowns in 2013 Description: Synopsis This
Decision Matrix: Selecting a CRM Vendor in the Pharmaceutical Market (Competitor Focus)
A Datamonitor report Decision Matrix: Selecting a CRM Vendor in the Pharmaceutical Market (Competitor Focus) Published: Oct 07 Product Code: DMTC2133 Providing you with: Identifies which technology vendors
Blockbuster!!! Content Management in the Pharmaceutical Industry An Overview. Global Pharma Market Shares by Sales (Approx. USD 700 Billion) Global
Content Management in the Pharmaceutical Industry An Overview Blockbuster!!! Avatar USD 2 Billion revenues Lipitor USD 12.5 Billion in 2008 Dr Arun Gangatkar http://in.linkedin.com/in/drarungangatkar [email protected]
Small-Cell Lung Cancer Global Clinical Trials Review, H2, 2015
Brochure More information from http://www.researchandmarkets.com/reports/3398017/ Small-Cell Lung Cancer Global Clinical Trials Review, H2, 2015 Description: Small-Cell Lung Cancer Global Clinical Trials
EU Clinical Trials Register
EU Clinical Trials Register Sponsor Contact Information Abbott Laboratories Ltd Abbott House, Vanwall Business Park, Vanwall Road, Maidenhead, Berkshire SL6 4XE UK Telephone number +44 1628 644475 [email protected]
2015 Employment Report
Corporate Connections. Career Results. 2015 Employment Report www.smeal.psu.edu/mba Corporate Connections. Career Results. 1 Table of Contents Class of 2015 Full-Time Employment Class of 2016 Internship
Main Conference Agenda
Sponsored by: (Co-located with Bioequivalence: Intersection between Science & Regulatory Conference) Main Conference Agenda Day One Wednesday, November 5 th, 2014 7:30 Registration Opens & Continental
Medical Writing Takes Off in India
Visit http://store.centerwatch.com to learn more about State of the Clinical Trials Industry 2008 Special Article Reprint For the latest news and views on the clinical trials industry visit ClinicalTrialsToday.com
In the largest and perhaps the most ambitious collaborative
FEATURES THE BIRTH OF TRANSCELERATE BIOPHARMA, INC. Revolution in Clinical Research Partnerships by Dalvir Gill and Garry Neil In the largest and perhaps the most ambitious collaborative effort ever initiated
The World's Top 100 Pharmaceutical Companies
Brochure More information from http://www.researchandmarkets.com/reports/1878687/ The World's Top 100 Pharmaceutical Companies Description: Did you know? - Dr. Jeremy Levin is Senior Vice President, Strategy,
Commercial Insight Osteoarthritis and Rheumatoid Arthritis
A Datamonitor In-Depth Analysis Commercial Insight Osteoarthritis and Rheumatoid Arthritis New Growth In A Mature Market Published: Jul-03 Product Code: DMHC1891 Why buy this analysis? Target current and
Pharmaceutical Marketing Disclosures
Pharmaceutical Marketing Disclosures July 1, 2007 June 30, 2008 Report of Vermont Attorney General William H. Sorrell April 2009 Prepared by staff of the Vermont Attorney General s Office: Wendy Morgan,
Clinical trial research agreement Agreed schedule 4 or 7 clause amendments
Clinical trial research agreement Agreed schedule 4 or 7 clause amendments Medicines Australia and Medical Technology Association of Australia templates The sponsors in the table have agreed clauses for
Pharma working capital performance highly variable
April 2014 Pharma working capital performance highly variable 41 Billion in Excess Working Capital We last completed this survey in 2012. We expected that there would be a broad improvement across the
The United States False Claims Act Qui Tam Whistleblower Law
The United States False Claims Act Qui Tam Whistleblower Law Getnick & Getnick LLP Counsellors At Law Rockefeller Center, 620 Fifth Avenue New York, NY 10020 Phone: (212) 376-5666 Fax: (212) 292 3942 www.getnicklaw.com
Stakeholder Perspectives: Mild Cognitive Impairment and Dementia
A Datamonitor In-Depth Analysis Stakeholder Perspectives: Mild Cognitive Impairment and Dementia Aricept in Race to Pioneer Unexplored Markets Published: Aug-03 Product Code: DMHC1924 Why buy this analysis?
KEEPING CLINICAL TRIALS IN AUSTRALIA
OCCASIONAL PAPER SERIES KEEPING CLINICAL TRIALS IN AUSTRALIA WHY ACTION IS NEEDED NOW OCCASIONAL PAPER SERIES > Medicines Australia is producing Occasional Papers to promote a contest of ideas, thought
Buying Process and Negociation. from a Group of Pharmacies Point of View
Buying Process and Negociation from a Group of Pharmacies Point of View Agenda: Demographics Sector Analysis Trends Pharmaceutical Market Overview Pharmaceutical Retails Market Overview The Future Business
Acknowledgements. Legal Notice
1 Acknowledgements The 2011 EU Industrial R&D Investment Scoreboard (Draft) has been published within the context of the Industrial Research Monitoring and Analysis (IRMA) activities that are jointly carried
Pharma RepTrak 2015 The World s Most Reputable Pharmaceutical Companies
Pharma RepTrak 2015 The World s Most Reputable Pharmaceutical Companies The Pharma Industry s Reputation in the Eyes of the General Public A Reputation Study with Consumers in 15 Countries RepTrak is a
Pharmaceutical industry
8 th March 2016 Pharmaceutical industry 2015 Global ranking strategy decisive The annual company reporting season is always an exciting period. It is an ideal time to update our industry statistics and
CODE FOR DISCLOSURE OF TRANSFERS OF VALUE BY PHARMACEUTICAL COMPANIES TO HEALTHCARE PROFESSIONALS AND HEALTH ORGANIZATIONS
CODE FOR DISCLOSURE OF TRANSFERS OF VALUE BY PHARMACEUTICAL COMPANIES TO HEALTHCARE PROFESSIONALS AND HEALTH ORGANIZATIONS Adopted November 2013, in force since 1 st of January 2014. INTRODUCTION The Association
Medical Professionalism in Lebanon: Challenges and Aspirations. Kamal F Badr, MD Associate Dean for Medical Education American University of Beirut
Medical Professionalism in Lebanon: Challenges and Aspirations Kamal F Badr, MD Associate Dean for Medical Education American University of Beirut Medical Professionalism in Lebanon: Challenges and Aspirations
Manufacturer of drug substance
Original s and Biosimilars (marketing authorizations in the EU) Date: January 2016 1) Somatropin s ORIGINAL PRODUCTS: Authorization Genentech Genotropin Somatropin Pharmacia/ Pfizer E. coli Humatrope Somatropin
INVESTMENT CHOICES. Dr. Suzanne B. Badenhop Professor/Extension Specialist
INVESTMENT CHOICES Dr. Suzanne B. Badenhop Professor/Extension Specialist INVESTING 101 What is your investment objective? What is your age? What is your time horizon What is your risk comfort level? What
INCENTIVE COMPENSATION CONFERENCE
Announcing the 2nd Annual ZS Associates INCENTIVE COMPENSATION CONFERENCE 08 September 23 24, 2008 Philadelphia, PA Incentive compensation greatly affects sales force motivation and morale. When designed
Stakeholder Insight: Insulin Use in Type 2 Diabetes
A Datamonitor Report Stakeholder Insight: Insulin Use in Type 2 Diabetes From Last Resort to Early Intervention Published: May-04 Product Code: DMHC1989 Providing you with: Analysis of Datamonitor s Diabetes
Pharma working capital leaves room for improvement
October 2012 Pharma working capital leaves room for improvement 50.7 Billion in Excess Working Capital Ten years ago it was not unusual to be asked why working capital mattered to a pharmaceutical company.
e-labeling : innovation for patient or regulation nightmare Pharmapack Feb, 11 th, 2015
e-labeling : innovation for patient or regulation nightmare Pharmapack Feb, 11 th, 2015 PHARMAPACK 2015 1 Mobile health x2 30 months 100 000 mapps Source: research2guidance, mhealth App Market Report 2013-2017
Pharmaceutical Products Liability. Michael C. Dubin Stephen Knobloch
Pharmaceutical Products Liability Michael C. Dubin Stephen Knobloch Objectives Objective 1 Get Actuaries Thinking About Adding Value to New Areas Objective 2 Provide example using pharmaceutical industry
Rx-360 An International Pharmaceutical Supply Chain Consortium
Rx-360 An International Pharmaceutical Supply Chain Consortium Overview Rx-360 and the Audit Sharing Program September 2011 Rx-360 Members (Continuously updated list at www.rx-360.org) Manufacturers (24)
M&A und Allianzen in Life Science Aktuelle Entwicklungen und Trends
M&A und Allianzen in Life Science Aktuelle Entwicklungen und Trends Symposium Life Science am Kapitalmarkt Frankfurt, 3. Juni 28 Global biotech industry Strong growth in most areas but Visible product
Global Pharmaceuticals Marketing Channel Reference EDITION
Global Pharmaceuticals Marketing Channel Reference EDITION 2015 ABOUT IMS HEALTH IMS Health is a leading global information and technology services company providing clients in the healthcare industry
PG Diploma in Clinical Research, Pharmacovigilance, Regulatory and Clinical Data Management
PG Diploma in Clinical Research, Pharmacovigilance, Regulatory and Clinical Data Management Contact: +91 9886735658, 080 28411665 ext 5103 Email: [email protected] PG Diploma In Clinical Research,
Company Overview June 2011
June 2011 Pop Design is the Architectural and Interior Design Company which was founded in 1992 by Architect Murat Fatih Mısırlı in İstanbul. More than 10.000 m 2 of corporate interior design & production
Outsourcing and Offshoring of R&D in the Pharmaceutical Industry: Evidence and Policy Implications from a Global Value Chain Analysis
Outsourcing and Offshoring of R&D in the Pharmaceutical Industry: Evidence and Policy Implications from a Global Value Chain Analysis Paulina Ramirez: Birmingham Business School IRIMA Workshop on the Internationalisation
Annual Press Conference 2012. Business Year 2011
Business Year 2011 Highlights of the Business Year 2011 Andreas Barner Chairman of the Board of Managing Directors Corporate Board Division Pharma Research, Development and Medicine Value through Innovation
Malignant Mesothelioma - Pipeline Review, H1 2015
Brochure More information from http://www.researchandmarkets.com/reports/3308784/ Malignant Mesothelioma - Pipeline Review, H1 2015 Description: Malignant Mesothelioma - Pipeline Review, H1 2015 Summary
Complying with the FCPA - An Exploration of Ethical Issues Raised by Recent Cases: Lessons Learned from Recent Enforcement Actions
Complying with the FCPA - An Exploration of Ethical Issues Raised by Recent Cases: Lessons Learned from Recent Enforcement Actions Philip S. Brewster Brewster Law Firm LLC July 29, 2014 Schering Charitable
Pertuzumab in Trastuzumab- Treated, Advanced HER2-Positive Breast Cancer
Pertuzumab in Trastuzumab- Treated, Advanced HER2-Positive Breast Cancer For more visit ResearchToPractice.com/5MJC CME INFORMATION OVERVIEW OF ACTIVITY Each year, thousands of clinicians and basic scientists
Outline of the case study analysis. Summary of analysis results
Outline of the case study analysis In order to examine how IAS 38 Intangible assets is applied in practice by EU corporations, we surveyed the accounting treatment of internally generated development costs
Multiple Sclerosis Therapeutics to 2019 - Treatment Diversification, Increasing Efficacy, and Pipeline Innovation Combine to Drive Growth
Brochure More information from http://www.researchandmarkets.com/reports/2640803/ Multiple Sclerosis Therapeutics to 2019 - Treatment Diversification, Increasing Efficacy, and Pipeline Innovation Combine
Metastatic Breast Cancer - Pipeline Review, Q1 2011
Brochure More information from http://www.researchandmarkets.com/reports/1524592/ Metastatic Breast Cancer - Pipeline Review, Q1 2011 Description: Metastatic Breast Cancer - Pipeline Review, Q1 2011 Summary
Commercial Perspectives: Multiple Sclerosis
A Datamonitor Report Commercial Perspectives: Multiple Sclerosis How to Find Opportunities in an Unremitting Market Published: Jun-04 Product Code: Providing you with: In-depth profiles of current market-leading
The Importance of the Pharmaceutical Industry for Switzerland
Study on behalf of Interpharma The Importance of the Pharmaceutical Industry for Switzerland BAK Basel Economics Michael Grass, Samuel Mösle In collaboration with Polynomics Published by: Interpharma,
The Cost of Innovation in the Pharmaceutical Industry A Review
The Cost of Innovation in the Pharmaceutical Industry A Review Prof. Dr. Alexander Schuhmacher, Reutlingen University, March 2014 Conflict of interest: nothing to disclose 1 Executive Summary Despite scientific,
Problems Facing the Pharmaceutical Industry and Approaches to Ensure Long Term Viability
University of Pennsylvania ScholarlyCommons Master of Science in Organizational Dynamics Theses Organizational Dynamics Programs 5-4-2010 Problems Facing the Pharmaceutical Industry and Approaches to Ensure
Biopharmaceutical Raw Materials throughout the Product Lifecycle
February 27 March 2, 2012 Hilton San Diego Bayfront San Diego, CA Monday Tuesday Programming: IBC s 17th International Process & Analytical Assay Validation IBC s 8th International Outsourcing Manufacturing
PHARMACEUTICAL INDUSTRY PROFILE
PHARMACEUTICAL INDUSTRY PROFILE I. INDUSTRY BACKGROUND A. Industry Definition The U.S. pharmaceutical industry is defined by the Census Bureau as companies engaged in researching, developing, manufacturing,
Discussion paper on global harmonization of the traceability system for drugs with globally harmonised barcodes
Purpose The purpose of this paper is to facilitate the discussions for a transition toward a globally harmonised barcoding system for pharmaceuticals in China, using GS1 global standards and building on
Notice of Annual General Meeting
Basel, February 3, 2014 To the shareholders of Novartis AG Notice of Annual General Meeting Date: Tuesday, February 25, 2014, 10.00 a.m. (doors open at 8.30 a.m.) Place: St. Jakobshalle, Basel (entrance
ACT-RAY and MRI substudy
Tocilizumab as Monotherapy or in Combination With Methotrexate associated with Early Reductions in Tissue Inflammation: 12-Week Results From a Magnetic Resonance Imaging Substudy of a Randomized Controlled
Why Choose Dundas Dashboard
Why Choose Dundas Dashboard Dundas Data Visualization, Inc. 250 Ferrand Drive, Suite 500 Toronto, ON Canada M3C 3G8 1.800.463.1492 1.416.467.9100 [email protected] www.dundas.com Table of Contents 1.0 Introduction
S&P 1500 Peer Group Report
S&P 1500 Peer Group Report 2014 Featuring Commentary From: About Equilar Equilar is the leading provider of executive compensation and corporate governance data for corporations, nonprofits, consulting
Carol Lefebvre Senior Information Specialist UK Cochrane Centre National Institute for Health Research Oxford, UK
Clinical trials registers and clinical trials results registers: their contribution as health information sources to evidence-based healthcare decision-making Carol Lefebvre Senior Information Specialist
PeopleMoves Asia Pacific
PeopleMoves Asia Pacific Q1 2012 It is generally agreed that the Western and Chinese approaches to leadership differ. Perhaps what is more important to consider is that due to rapid growth and change in
CO-PAY PROGRAMS FOR HIV and Hepatitis
CO-PAY PROGRAMS FOR HIV and Hepatitis CO-PAY PROGRAMS FOR HIV These programs offer assistance to people with private health insurance for the co-payments they have to make at the pharmacy for their HIV
Six Sigma strategy applied to the pharmaceutical industry how customers benefit.
Six Sigma strategy applied to the pharmaceutical industry - how customer benefit MBA Thesis 2009 School of Management Blekinge Institute of Technology Six Sigma strategy applied to the pharmaceutical industry
How To Manage Reputation
2013 Global CSR RepTrak 100 Top Line Report The Best CSR in the World Reputation study with Consumers in 15 Countries RepTrak is a registered trademark of Reputation Institute. Copyright 2013 Reputation
1) SCOPE OF THE PROGRAM
CALL FOR PROJECTS 2015/16 CANADA/GERMANY JOINT PROGRAM DEADLINE: 15 TH JANUARY 2016 1) SCOPE OF THE PROGRAM The main goal of the Canada/Germany joint program is to strengthen research in Canada and Germany
Family Practitioners, General Practitioners, Internists, Physician Assistants, Nurse Practitioners, and Nurses
36 th Annual Family Practice Review Online Planned and produced in accordance with the ACCME essentials. RELEASE DATE: February 25, 2013 EXPIRATION DATE: February 25, 2015 Physicians $750 Non-Physicians
NCPA 2006 Exhibitors (as of 9/25/06) American Pharmacists Association www.aphanet.org Booth 907. /alert Marketing www.alertmarketing.
NCPA 2006 Exhibitors (as of 9/25/06) /alert Marketing www.alertmarketing.com Booth 530 21st Century Healthcare www.21stcenturyvitamins.com Booth 147 A & D Medical Lifesource www.lifesourceonline.com Booth
Stakeholder Insight: Rheumatoid Arthritis Biologics battle up the treatment algorithm
A Datamonitor report Stakeholder Insight: Rheumatoid Arthritis Biologics battle up the treatment algorithm Published: Sep-06 Product Code: Providing you with: Disease overview including epidemiology, physician
Marriott Courtyard Philadelphia Airport November 6 & 7, 2014
ADVANCING INTERACTION, DIALOGUE AND ACCELERATING DECISIONS Marriott Courtyard Philadelphia Airport November 6 & 7, 2014 ADVANCED SALES TRAINING Presented by Brennan Sales Institute Authors of McGraw Hill
Creating Joint Value. In Biopharma and Many Other Industries, Not Invented Here Is SO Last Century. By Ben Gomes-Casseres
Creating Joint Value In Biopharma and Many Other Industries, Not Invented Here Is SO Last Century By Ben Gomes-Casseres 36 STRATEGIC ALLIANCE MAGAZINE Q3 2014 Look at any of your alliances. How do you
Brochure More information from http://www.researchandmarkets.com/reports/3292678/
Brochure More information from http://www.researchandmarkets.com/reports/3292678/ Asia Pacific (India, China, Australia, South Korea & Others) Insulin Market (Rapid Acting, Short Acting, Pre-Mixed, Long
位 参 加 者 将 来 制 定 策 略 和 规 划 提 供 非 常 有 用 的 参 考. Changing Paradigm in Drug Discovery and Development: East Meets West SHANGHAI
PRELIMINARY Program AGENDA Shanghai Symposium on Chemical and Pharmaceutical Structure Analysis Revised Jan 24, Changing Paradigm in Drug Discovery and Development: East Meets West Renaissance Shanghai
The PROTECT project. Introduction. Xavier Kurz Pharmacovigilance and Risk management Patient Health Protection Unit European Medicines Agency
The PROTECT project Introduction Xavier Kurz Pharmacovigilance and Risk management Patient Health Protection Unit European Medicines Agency Brookings Active Surveillance Implementation Council Meeting
This continuing education activity is co-sponsored by Indiana University School of Medicine and by CME Outfitters, LLC.
This continuing education activity is co-sponsored by Indiana University School of Medicine and by CME Outfitters, LLC. Indiana University School of Medicine and CME Outfitters, LLC, gratefully acknowledge
Spain s Most Attractive Employers 2016 STUDENTS
Spain s Most Attractive Employers 2016 STUDENTS 2 THE MOST ATTRACTIVE EMPLOYERS 2016 Where do you rank? Today s businesses operate in a highly competitive employment landscape, and you can gain a valuable